# Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/pembrolizumab-as-second-line-therapy-for-advanced-urothelial-carcinoma/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Joaquim Bellmunt,Ronald de Wit,David J. Vaughn,Yves Fradet,Jae‐Lyun Lee,Lawrence Fong,Nicholas J. Vogelzang,Miguel Ángel Climent,Daniel P. Petrylak,Toni K. Choueiri,Andrea Necchi,Winald R. Gerritsen,Howard Gurney,David I. Quinn,Stéphane Culine,Cora N. Sternberg,Yabing Mai,Christian Poehlein,Rodolfo F. Perini,Dean F. Bajorin |
| Citations | 3,424 |
| DOI | 10.1056/nejmoa1613683 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.nejm.org/doi/pdf/10.1056/NEJMoa1613683?articleTools=true |
| OpenAlex ID | https://openalex.org/W2588916311 |
| PMID | 28212060 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Toni K. Choueiri](https://scholariq.org/researchers/toni-k-choueiri/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)

## Paper topics

- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Ferroptosis and cancer prognosis](https://scholariq.org/topics/ferroptosis-and-cancer-prognosis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.